Skip to main content

Table 1 Baseline characteristics of patients with dilated cardiomyopathy with or without diabetes

From: Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy

Variable DM group No DM group P value
No. of patients 46 43  
Age (years) 60.9 ± 11.2 61.6 ± 13.2 0.758
Male, N (%) 29 (63%) 24 (56%) 0.487
Body mass index (kg/m2) 24.0 ± 3.2 23.8 ± 4.0 0.792
Hypertension, N (%) 28 (61%) 9 (21%) <0.001*
Laboratory profiles
 Creatinine (mg/dL) 2.4 ± 2.8 1.1 ± 0.2 0.006
 eGFR (mL/min/1.73 m2) 53.1 ± 31.2 70.6 ± 17.0 0.002
 Total cholesterol (mg/dL) 167.6 ± 39.2 159.6 ± 40.1 0.361
 Triglycerides (mg/dL) 130.3 ± 78.2 140.5 ± 121.9 0.874
 HDL cholesterol (mg/dL) 45.0 ± 14.3 47.3 ± 12.9 0.386
 LDL cholesterol (mg/dL) 92.7 ± 37.0 97.3 ± 23.6 0.600
Medication, N (%)
 Anticoagulants 32 (70%) 31 (72%) 0.793
 β-Blockers 26 (57%) 23 (53%) 0.774
 ACEI/ARB 40 (87%) 38 (88%) 0.839
 CCB 1 (2%) 2 (5%) 0.518
 Diuretics 28 (61%) 29 (67%) 0.518
 Statins 15 (33%) 6 (14%) 0.038*
  1. ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker, DM diabetes mellitus, eGFR estimated glomerular filtration rate, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. P < 0.05 by Chi square test
  3. P < 0.05 by independent t test or Mann–Whitney test